Skip to content

The effect of giving a Drug to block nerves supplying Kidneys to reduce Blood loss during Surgery for removal of Kidney Stones.

Effect of Paravertebral Block on reducing blood loss in Percutaneous Nephrolithotomy (PCNL) surgeries : Randomized Controlled Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027909
Enrollment
50
Registered
2020-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: using paravertebral block on the side of the percutaneous nephrolithostomy surgery: using paravertebral block on the side of the percutaneous nephrolithostomy surgery prior to surgery.

Sponsors

RajaRajeswari Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA status I and II Undergoing unilateral PCNL surgeries.

Exclusion criteria

Exclusion criteria: Patients refusing to participate in the study 2. Patient with uncontrolled hypertension, diabetes, cardio-respiratory disorders, neuro-psychiatric disorders, hepatic or renal dysfunction. 3. Coagulopathy, infection at the site of block, neurological deficits. 4. Patients on medications like opioids, sedatives, anti-psychotics, anti-epileptics. 5. Pregnant or lactating mothers. 6.Alcoholic 7.Allergic to study drug

Design outcomes

Primary

MeasureTime frame
To Determine Reduction in Blood loss in patients receiving Paravertebral Block prior to PCNL Surgery.Timepoint: To Determine Reduction in Blood loss in patients receiving Paravertebral Block prior to PCNL Surgery. 3 Months

Secondary

MeasureTime frame
To Check Safety Profile of Paravertebral Block in PCNL Surgery in regards to Hemodynamic ParametersTimepoint: 3 Months

Countries

India

Contacts

Public ContactDr Rashmi

RajaRajeswari Medical College and Hospital

rashmi.rp16@gmail.com9986665368

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026